Literature DB >> 1473122

Barriers to cervical cytology screening in native women in British Columbia.

M Deschamps1, P R Band, T G Hislop, H F Clarke, J M Smith, V To Yee Ng.   

Abstract

The British Columbia (BC) Cervical Cytology Screening Programme (CCSP), implemented since 1955, has resulted in a 75% decrease in both the mortality from and incidence of invasive squamous cervical carcinoma. However, despite this effect, the Native Indian population still present an overall mortality rate four times higher than that of the non-Native population. A demonstration project was initiated in four Native Indian Band communities of BC to determine the reasons underlying these findings. The participation patterns to the CCSP were investigated and revealed that the overall percentage of participation to the CCSP among Native Indian women was 30% lower than that of the non-Native population. Reasons for the under-participation to the CCSP were explored. A total of 36 women, 9 in each of the 4 communities, including current users, ex-users and never users, were interviewed. Reasons for not participating in the CCSP were due mainly to (1) the lack of knowledge about the Pap test and about its importance; (2) feelings of embarrassment and shamefulness; (3) lack of continuity of care due to the high turnover of physicians in the Native communities. Based on the study findings, a pilot CCSP clinic will be implemented in each community. In addition to taking cervical smears, this pilot project will include education sessions, notification about the results of the test, and recall for annual check up.

Entities:  

Mesh:

Year:  1992        PMID: 1473122

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  9 in total

1.  Pap screening clinics with native women in Skidegate, Haida Gwaii. Need for innovation.

Authors:  B Calam; L Norgrove; D Brown; M A Wilson
Journal:  Can Fam Physician       Date:  1999-02       Impact factor: 3.275

2.  Maintaining mammography adherence through telephone counseling in a church-based trial.

Authors:  N Duan; S A Fox; K P Derose; S Carson
Journal:  Am J Public Health       Date:  2000-09       Impact factor: 9.308

3.  Monitoring disease burden and preventive behavior with data linkage: cervical cancer among aboriginal people in Manitoba, Canada.

Authors:  T K Young; E Kliewer; J Blanchard; T Mayer
Journal:  Am J Public Health       Date:  2000-09       Impact factor: 9.308

4.  Facilitators and barriers to cervical cancer screening among Chinese Canadian women.

Authors:  T G Hislop; M Deschamps; C Teh; C Jackson; S P Tu; Y Yasui; S M Schwartz; A Kuniyuki; V Taylor
Journal:  Can J Public Health       Date:  2003 Jan-Feb

Review 5.  The Asian Women's Health Clinic: addressing cultural barriers to preventive health care.

Authors:  L Sent; P Ballem; E Paluck; L Yelland; A M Vogel
Journal:  CMAJ       Date:  1998-08-25       Impact factor: 8.262

6.  Teaching tools to engage Anishinaabek First Nations women in cervical cancer screening: Report of an educational workshop.

Authors:  Ingeborg Zehbe; Brianne Wood; Pamela Wakewich; Marion Maar; Nicholas Escott; Naana Jumah; Julian Little
Journal:  Health Educ J       Date:  2016-04-01

7.  Cervical cytology screening. How can we improve rates among First Nations women in urban British Columbia?

Authors:  T G Hislop; H F Clarke; M Deschamps; R Joseph; P R Band; J Smith; N Le; R Atleo
Journal:  Can Fam Physician       Date:  1996-09       Impact factor: 3.275

8.  Determinants of womens participation in cervical cancer screening trial, Maharashtra, India.

Authors:  Bhagwan Nene; Kasturi Jayant; Silvina Arrossi; Surendra Shastri; Atul Budukh; Sanjay Hingmire; Richard Muwonge; Sylla Malvi; Ketayun Dinshaw; Rengaswamy Sankaranarayanan
Journal:  Bull World Health Organ       Date:  2007-04       Impact factor: 9.408

9.  Inuit women's attitudes and experiences towards cervical cancer and prevention strategies in Nunavik, Quebec.

Authors:  Helen Cerigo; Mary Ellen Macdonald; Eduardo L Franco; Paul Brassard
Journal:  Int J Circumpolar Health       Date:  2012-03-19       Impact factor: 1.228

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.